Healthcare Technology
Search documents
UniDoc Completes H3 Health Cube Installation in Italy
Accessnewswire· 2025-12-17 13:00
AI assisted Health Cube open to patients in Guardia Perticara (Basilicata), Italy VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce that it has completed installation of its H3 Health Cube in Italy. Sold through UniDoc's in-country partner, UniCheck SRL, the Health Cube at the Territorial eHealth Centre in Guardia Perticara (Basilicata), Italy, reflects continued execution in the Basilicata region. ...
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network
Globenewswire· 2025-12-17 09:30
Core Viewpoint - OptimizeRx Corp. has announced four new partner agreements that significantly enhance its point-of-care (POC) network, strengthen its competitive position, and expand its National Provider Identifier (NPI) reach [1][2]. Partnership Agreements - The new agreements include partnerships with an eRx platform and a health systems access partner, which together increase OptimizeRx's unique NPI reach by 37% [3][9]. - The eRx platform was previously part of a competitive network, while the health systems access partner allows OptimizeRx to engage healthcare professionals (HCPs) at critical points in patient care [3][9]. Strategic Footprint Expansion - These partnerships reinforce OptimizeRx's leadership in the POC marketing landscape and secure exclusive access to premium inventory, enhancing visibility into future channel revenue [4][10]. - Renewals with top-performing EHR and eRx platforms further solidify these relationships, based on historical strong utilization and high returns on investment (ROIs) for life sciences brands [4][10]. Growth Positioning - The CEO of OptimizeRx emphasized that deepening relationships with high-value partners and gaining access to large-scale platforms positions the company for sustained, profitable growth [5]. - The company aims to enhance its clients' ability to reach a larger audience of relevant providers, driving brand awareness and conversion [5][10]. Technology and Innovation - OptimizeRx utilizes innovative, AI-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood® Targeting (MNT) to facilitate timely and relevant engagement between life sciences brands and healthcare providers [6]. - The company's commitment to privacy-safe, patient-centric technology aims to deliver impactful interactions that improve patient outcomes [7].
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
Globenewswire· 2025-12-16 21:05
Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company utilizes its software platform, Clover Assistant, to aggregate patient data across the healthcare ecosystem, supporting clinical decision-making and improving health outcomes through early identification and management of chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans in multiple states, emphasizing its flagship wide-network, high-choice PPO plans [2] Technology and Impact - The technology platform has demonstrated positive impacts on various health metrics, including Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and outcomes in Underserved Populations [2] - The company aims to enhance patient outcomes and reduce healthcare costs on a nationwide scale through its subsidiary, Counterpart Health, which extends the benefits of its data-driven technology to a broader audience [2] Upcoming Events - The CEO of Clover Health, Andrew Toy, is scheduled to present at the J.P. Morgan 2026 Healthcare Conference on January 15, 2026, at 11:15 a.m. Eastern Time, with a live webcast available on the company's investor relations website [1]
Hims & Hers Scales Technology-Driven Care as Profitability Evolves
ZACKS· 2025-12-16 18:16
Core Insights - Hims & Hers Health, Inc. (HIMS) demonstrates a growth trajectory where scale, profitability, and reinvestment are developing simultaneously, with Q3 2025 revenues approaching $600 million and positive net income despite significant investments in technology and marketing [1][7] Group 1: Financial Performance - HIMS reported a net income in Q3 2025 while continuing to invest heavily in technology, marketing, and platform expansion [7] - The Zacks Consensus Estimate for HIMS' 2025 earnings per share indicates a 77.8% improvement from 2024 [8] - HIMS shares have increased by 16.5% over the past year, outperforming the industry decline of 3.7% [6] Group 2: Strategic Developments - HIMS is expanding its platform from episodic care to personalized, longitudinal health management, with new offerings in lab testing, weight-loss, hormone health, and women's health specialties [2] - The acquisition of YourBio Health and the appointment of an AI-focused chief technology officer emphasize HIMS' commitment to data, personalization, and user experience as growth drivers [2] - Geographic expansion into Canada, the U.K., and Europe reflects confidence in the business model, with management accepting near-term margin volatility for long-term growth [3] Group 3: Valuation Metrics - HIMS has a forward 12-month price-to-sales (P/S) ratio of 3X, which is lower than the industry average of 4.7X but higher than its three-year median of 2.6X [10] - HIMS currently holds a Zacks Rank 3 (Hold) [12]
DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare
Globenewswire· 2025-12-16 14:00
BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence (AI) for the early detection of eye-related health issues, is pleased to announce the appointment of Dr. Ismail Ben Ayed, as Chief Artificial Intelligence (AI) Scientist. Mr. Ben Ayed is an expert in medical image analysis algorithms, machine learning and computer vision. Mr. Ben Ayed will guide the Company’ ...
全球领先,港仔机器人主动健康中医大模型勇夺MedBench排名榜首
Zhi Tong Cai Jing· 2025-12-16 05:31
港仔机器人主动健管团队利用自研算法重构了中医古籍、现代权威教材及百万级医学问答对,构建了高质量训练数据集,采用指令微调技术,成功将异构的 中医理论体系深度内化为模型参数,赋予了HKR_TCM_HW_v1 强大的中医综合能力。 HKR_TCM_HW_v1 不仅实现了中医大模型技术的新突破,更为中医主动健康管理提供了全新视角。港仔机器人主动健管团队以HKR_TCM_HW_v1为核 心,打造了中医养生超级智能体,作为港仔机器人 AI 主动健康中心全流程服务的核心引擎,为用户提供中医健康分析、中医健康调控方案生成等一站式服 务。 该榜单的支持单位还包括上海中医药大学、中国中医科学院。MedBench平台全方位考察了大模型中医综合能力,紧扣中医基础、经典理解、临床诊疗、中 药方剂、针灸推拿五大核心维度,以多维度试题及真实临床病案场景设计考题,力求精准评估模型的中医专业素养与实战应用水平。 AI 主动健康中心,由香港本土首家具身智能机器人企业港仔机器人与国内预防医学领军企业美年健康(002044)联合研发,是新一代智能健康管理解决方 案的标杆之作。 智通财经APP了解到,近日,由上海人工智能实验室(人工智能领域国家级研发 ...
Wolters Kluwer Experts Forecast Deeper Healthcare AI Penetration in 2026, Enabled by Momentum in Workflow Integration and Governance
Businesswire· 2025-12-15 14:30
Core Insights - The healthcare sector is expected to see significant gains in AI adoption as 2026 approaches, with a focus on strategic implementation of productivity enablers and advancements in clinical decision-making technology [1] Group 1: AI Adoption in Healthcare - Predictions indicate that the healthcare industry will increasingly adopt AI technologies to enhance productivity and improve patient care [1] - Experts from Wolters Kluwer Health are highlighting the obstacles and opportunities that lie ahead in healthcare technology as the industry moves towards 2026 [1]
蚂蚁做健康,底气在哪?
虎嗅APP· 2025-12-15 14:18
Core Viewpoint - Ant Group is focusing on the health sector as a key area of its AI strategy, with the recent upgrade of its AI health application AQ to "Ant Aifu" marking a significant evolution from an AI tool to an AI health companion [2][10]. Group 1: Product Development and Market Response - The new version of the app quickly reached the top 6 in the Apple App Store download rankings within 24 hours of its release [3]. - Ant Group has made significant moves in the AI field over the past month, including a major organizational restructuring and the launch of the general assistant "Lingguang," indicating a clear strategy of advancing both general and specialized AI simultaneously [5][6]. Group 2: Market Trends and User Demand - There is a growing structural change in health demand among the public, with a shift in focus from "treating illness" to "preventing illness," and a younger demographic increasingly interested in health management [14]. - The aging population in China is projected to reach 310 million by the end of 2024, creating a long-term demand for health management services [14]. - Ant Aifu addresses a significant gap in the market for reliable health information, answering over 5 million questions daily, with 55% of inquiries coming from lower-tier cities [14]. Group 3: Competitive Landscape and Strategic Positioning - Ant Group's approach to AI is characterized by a dual strategy of general and specialized AI, with "Lingguang" focusing on creating simple applications and "Ant Aifu" targeting the health sector [8][22]. - The rapid growth of "Ant Aifu," achieving a monthly active user growth rate of 83.4%, significantly outpaces the industry average of 13.5% [8]. Group 4: Trust and Professionalism in Health AI - The health sector is sensitive to reliability and professionalism, making user trust a critical asset for health AI applications [19][24]. - Ant Aifu's success is attributed to its deep understanding of the health industry, a solid user base, and a robust technical foundation built over years of experience [16][19].
CareCloud Launches stratusAI Desk Agent, A Breakthrough AI Front Desk Assistant That Transforms Phone-Based Patient Access
Globenewswire· 2025-12-15 13:00
Core Insights - CareCloud has launched stratusAI Desk Agent, an AI-driven phone receptionist aimed at modernizing patient phone interactions and automating call center workflows [1][2][3] Group 1: Product Features and Benefits - stratusAI Desk Agent manages nearly 80% of inbound calls for medical practices, allowing staff to focus on complex patient needs while maintaining service quality [2] - The AI solution provides 24/7 phone access through autonomous, human-like conversations, enhancing patient engagement and operational efficiency [3][4] - It automates various tasks including appointment scheduling, call triage, prescription refill requests, and responses to common patient inquiries [6] Group 2: Market Opportunity - The total addressable market for stratusAI Front Desk in the U.S. is estimated to exceed $4 billion annually, representing significant growth potential in healthcare technology [5] - CareCloud is positioned to lead the transformation in healthcare by automating high-volume call operations, which are critical for patient access and operational efficiency [5] Group 3: Integration and Analytics - stratusAI Desk Agent, when combined with stratusAI Voice Audit, offers end-to-end visibility into the patient phone experience, providing actionable intelligence for administrators [5][7] - The integration allows for in-depth call monitoring, quality scoring, and insights into call volumes and service levels, enhancing operational oversight [7]
X @The Wall Street Journal
The Wall Street Journal· 2025-12-11 18:56
Texas sued healthcare technology giant Epic Systems, alleging the company’s setup can block parents from accessing their children’s health information https://t.co/ngpNt68MFt ...